Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease. (Record no. 6103481)

MARC details
000 -LEADER
fixed length control field 01466 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512194949.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198007s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0140-6736
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/s0140-6736(80)91496-8
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Douglas, D L
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19800726
245 00 - TITLE STATEMENT
Title Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Lancet (London, England)
Date of publication, distribution, etc. May 1980
300 ## - PHYSICAL DESCRIPTION
Extent 1043-7 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Alkaline Phosphatase
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bone Resorption
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Calcium
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clodronic Acid
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diphosphonates
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hydroxyproline
General subdivision urine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypercalcemia
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hyperparathyroidism
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Osteitis Deformans
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Duckworth, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Russell, R G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kanis, J A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Preston, C J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Preston, F E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Prenton, M A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Woodhead, J S
773 0# - HOST ITEM ENTRY
Title Lancet (London, England)
Related parts vol. 1
-- no. 8177
-- p. 1043-7
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/s0140-6736(80)91496-8">https://doi.org/10.1016/s0140-6736(80)91496-8</a>
Public note Available from publisher's website

No items available.